1. Home
  2. EXAS vs TTC Comparison

EXAS vs TTC Comparison

Compare EXAS & TTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • TTC
  • Stock Information
  • Founded
  • EXAS 1995
  • TTC 1914
  • Country
  • EXAS United States
  • TTC United States
  • Employees
  • EXAS N/A
  • TTC N/A
  • Industry
  • EXAS Medical Specialities
  • TTC Tools/Hardware
  • Sector
  • EXAS Health Care
  • TTC Consumer Discretionary
  • Exchange
  • EXAS Nasdaq
  • TTC Nasdaq
  • Market Cap
  • EXAS 10.2B
  • TTC 7.7B
  • IPO Year
  • EXAS N/A
  • TTC N/A
  • Fundamental
  • Price
  • EXAS $53.43
  • TTC $79.59
  • Analyst Decision
  • EXAS Strong Buy
  • TTC Buy
  • Analyst Count
  • EXAS 22
  • TTC 4
  • Target Price
  • EXAS $67.38
  • TTC $90.75
  • AVG Volume (30 Days)
  • EXAS 2.8M
  • TTC 859.7K
  • Earning Date
  • EXAS 11-04-2025
  • TTC 09-04-2025
  • Dividend Yield
  • EXAS N/A
  • TTC 1.92%
  • EPS Growth
  • EXAS N/A
  • TTC N/A
  • EPS
  • EXAS N/A
  • TTC 3.29
  • Revenue
  • EXAS $2,939,949,000.00
  • TTC $4,520,200,000.00
  • Revenue This Year
  • EXAS $16.50
  • TTC N/A
  • Revenue Next Year
  • EXAS $12.32
  • TTC $3.15
  • P/E Ratio
  • EXAS N/A
  • TTC $24.10
  • Revenue Growth
  • EXAS 12.55
  • TTC 0.65
  • 52 Week Low
  • EXAS $38.81
  • TTC $62.34
  • 52 Week High
  • EXAS $72.83
  • TTC $89.50
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 61.45
  • TTC 53.31
  • Support Level
  • EXAS $46.30
  • TTC $78.16
  • Resistance Level
  • EXAS $56.52
  • TTC $80.15
  • Average True Range (ATR)
  • EXAS 1.63
  • TTC 1.89
  • MACD
  • EXAS 0.69
  • TTC -0.38
  • Stochastic Oscillator
  • EXAS 71.39
  • TTC 32.63

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About TTC Toro Company (The)

The Toro Co manufactures turf maintenance and landscaping equipment. The company produces reel and rotary riding products, trim cutting and walking mowers, greens rollers, turf sprayer equipment, underground irrigation systems, heavy-duty walk-behind mowers, and sprinkler systems used for professional turf and landscape maintenance and construction. Its products are marketed through a network of distributors and dealers to predominantly professional users maintaining turfs and sports fields such as golf courses. Its operating segments are Professional which generates a substantial part of its revenue, and Residential segment. The company also produces snow plowers and ice management products. Its key revenue generating market is the United States.

Share on Social Networks: